Impact of BRCA1 and BRCA2 Genetic Mutations on Breast Cancer Risk
Understanding BRCA1 and BRCA2 Genes
Women carrying genetic mutations in the BRCA1 and BRCA2 genes, particularly those with two or more close relatives affected by breast cancer, face a nearly doubled risk of developing the disease compared to those without a family history. BRCA1 and BRCA2 are essential human genes that produce proteins that play a crucial role in tumor suppression. Mutations in these genes significantly elevate the likelihood of breast and ovarian cancers.
Significance of Age-Specific Cancer Risk Estimates
Accurate age-specific estimates of cancer risk are vital for providing optimal clinical care to women with BRCA1 and BRCA2 mutations. A recent study conducted by Karoline Kuchenbaecker and her research team, published in the Journal of the American Medical Association, aimed to estimate these risks using data from multiple long-term cancer studies.
Study Overview and Participants
The research analyzed data from 3,886 participants with BRCA1 and BRCA2 mutations for breast cancer risk and 5,066 participants for ovarian cancer risk. The median age of participants at the study’s commencement was 38 years.
Cumulative Risks of Breast Cancer
For BRCA1 mutation carriers, the cumulative risk of developing breast cancer by age 80 was estimated at 72% (95% CI, 65%-79%). Likewise, BRCA2 carriers exhibited a similar risk, with an estimated 75% (95% CI, 67%-83%) by age 80. Notably, the cumulative risk by age 50 was found to be higher for BRCA1 carriers (p = 0.03) compared to BRCA2 carriers.
Ovarian Cancer Risk Analysis
The study also highlighted an increased incidence of ovarian cancer among participants aged 61 to 70 who had either BRCA1 or BRCA2 mutations. The cumulative risk of ovarian cancer by age 80 was significantly greater for BRCA1 carriers, at 44% (95% CI, 36%-53%), compared to 17% (95% CI, 11%-25%) for BRCA2 carriers.
Impact of Family History on Cancer Risk
Additionally, the study revealed that breast cancer risk estimates for women with BRCA1 or BRCA2 mutations escalated with an increasing number of first- and second-degree relatives diagnosed with breast cancer. Women with either mutation and two or more diagnosed relatives were almost twice as likely to develop breast cancer compared to those without such a family history.
Implications for Cancer Risk Management
The findings underscore the critical role of family history in managing cancer risk and may assist healthcare providers in delivering enhanced care to women facing multiple risk factors for breast and ovarian cancers.
Author and Source Information
Written By: Cindi A. Hoover, Ph.D.
Source: Kuchenbaecker K, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, and the BRCA1 and BRCA2 Cohort Consortium. 2017. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Journal of the American Medical Association. 317:23:2402-2416.